Dr. Joel Neal summarizes preliminary results of the SELECT trial
of adjuvant Tarceva (erlotinib) for patients with resected EGFR
mutation-positive early stage non-small cell lung cancer.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.